Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
Locations
  • HealthONE Clinic Services Oncology-Hematology Denver, Colorado, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
  • The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
  • Washington University School of Medicine Seattle, Washington, United States
View Trial Details
Completed

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

NCT03810807

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

NCT05005429

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
  • Hospital Parc Taulí Barcelona, Spain
View all 15 locations
View Trial Details
Completed

Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy

NCT04471428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Stanford University Palo Alto, California, United States
  • Kaiser Permanente - San Diego San Diego, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 92 locations
View Trial Details
Completed

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

NCT04965090

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

NCT03215706

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Memorial Health Systems Colorado Springs, Colorado, United States
  • Local Institution - 0044 Plainville, Connecticut, United States
  • Local Institution - 0045 Jacksonville, Florida, United States
  • Local Institution - 0029 Marietta, Georgia, United States
View all 116 locations
View Trial Details
Completed

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

NCT04349267

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +22 more
Locations
  • Local Institution - 0028 Sioux Falls, South Dakota, United States
  • Local Institution - 0001 Germantown, Tennessee, United States
  • Local Institution - 0014 Edmonton, Alberta, Canada
  • Local Institution - 0011 Vancouver, British Columbia, Canada
View Trial Details

Related conditions